Enter assignee name

EPO Patents = 1

Forward Citations = 442

Loading Chart...

9 inventors (with patents filed for the assignee):

Richard L Wahl (4 out of 18 patents)

Mark S Kaminski (4 out of 6 patents)

Gregory M Butchko (4 out of 6 patents)

4. Stephan D Glenn (4 out of 13 patents)

5. David Colcher (2 out of 2 patents)

6. Dan Shochat (2 out of 2 patents)

7. Michael J Buckley (2 out of 2 patents)

8. Albert S K Chan (1 out of 1 patent)

9. Albert S Chan (1 out of 1 patent)

10. Sanjeev Gangwar (73 patents)

11. Geoffrey T Yarranton (28 patents)

12. Vincent Dubois (6 patents)

13. Evan Lewis (2 patents)

14. Matthew H Nieder (10 patents)

15. André Trouet (4 patents)

6 patents: Sort by Forward Citations

1. 6338835 - Radioprotectant for peptides labeled with radioisotope (2002-01-15),

2. 6090365 - Radioimmunotherapy of lymphoma using anti-CD20 antibodies (2000-07-18),

3. 6015542 - Radioimmunotherapy of lymphoma using anti-CD20 antibodies (2000-01-18),

4. 5961955 - Radioprotectant for peptides labeled with radioisotope (1999-10-05),

5. 5843398 - Radioimmunotherapy of lymphoma using anti-CD20 antibodies (1998-12-01),

6. 5595721 - Radioimmunotherapy of lymphoma using anti-CD20 (1997-01-21),

Coulter Pharmaceutical, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for cancer and other serious diseases. With a focus on precision medicine, Coulter Pharma aims to bring personalized treatments to patients in need. Through cutting-edge research and strategic partnerships, the company is leading the way in delivering targeted therapies that improve outcomes and quality of life for patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

6 Patents

#134 in South San Francisco, CA

#10,317 in California

#43,910 in US

South San Francisco, CA, United States of America

Coulter Pharmaceutical, Inc.